Lamotrigine

Lamotrigine, lamotrigine, 84057-84-1, 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamictal, Lamictal Cd, Lamotrigina, Lamictal XR, Lamotriginum, BW 430C, 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, BW-430C, Lamictal ODT, 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-, 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine, BW430C, DTXSID2023195, NSC-759171, SUBVENITE, GW 273293, U3H27498KS, CHEBI:6367, DTXCID203195, Lamotirigine, Lamotrigine ER, LAMOTRIGINE Kit, RefChem:5936, lamotrigine extended-release, Lamotrigine Extended Release, lamotrigine chewable dispersible, N03AX09, 281-901-8, 658-035-8, Lamotriginum [Latin], Lamotrigina [Spanish], Labileno, Lamitor, C9H7Cl2N5, MFCD00865333, LTG, BW430C, CHEMBL741, MLS000069685, s3024, NCGC00015605-06, Lamictin, SMR000058464, 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine, (6M)-6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamictal (TN), CAS-84057-84-1, SR-01000000187, EINECS 281-901-8, Epilepax, UNII-U3H27498KS, Lamictal, , Lamotrigine CRS, HSDB 7526, EUR-1048, IYJ, Lamotrigine [USAN:USP:INN:BAN], Opera_ID_12, Lamotrigine (Standard), Tocris-1611, LAMOTRIGINE [MI], LAMOTRIGINE [INN], LAMOTRIGINE [JAN], Lopac-L-3791, LAMOTRIGINE [HSDB], LAMOTRIGINE [USAN], L 3791, LAMOTRIGINE [MART.], Lopac0_000688, SCHEMBL35439, LAMOTRIGINE [USP-RS], LAMOTRIGINE [WHO-DD], MLS000759486, MLS001077325, MLS001423991, BIDD:GT0794, Lamotrigine (JAN/USP/INN), Lamotrigine, >=98%, powder, GTPL2622, orb1310392, orb3141187, Lamotrigine, 1mg/ml in Ethanol, Lamotrigine - Bio-X trade mark, SCHEMBL29360953, SCHEMBL29801510, HY-B0495R, LAMOTRIGINE [EP IMPURITY], LAMOTRIGINE [ORANGE BOOK], GLXC-07355, HMS2051C10, HMS2089M08, HMS2093P21, HMS2230L04, HMS3262I17, HMS3268G17, HMS3371O16, HMS3393C10, HMS3657A17, HMS3715H21, HMS3885M03, HMS5081I06, LAMOTRIGINE [EP MONOGRAPH], LAMOTRIGINE [USP IMPURITY], Pharmakon1600-01505610, LAMOTRIGINE [USP MONOGRAPH], HY-B0495, Lamotrigine 1.0 mg/ml in Methanol, MSK10267, Tox21_110179, Tox21_500688, BDBM50031299, EBC-03614, HB0368, NSC746307, NSC759171, STK628377, AKOS005561147, Lamotrigine for system suitability CRS, Tox21_110179_1, 6-(2,2,4-triazine-3,5-diyldiamine, CCG-100856, DB00555, ID58057, KS-1074, Lamotrigine for peak identification CRS, LP00688, NC00106, NSC 746307, NSC 759171, NSC-746307, SDCCGSBI-0050666.P003, SMP2_000303, NCGC00015605-01, NCGC00015605-02, NCGC00015605-03, NCGC00015605-04, NCGC00015605-05, NCGC00015605-07, NCGC00015605-08, NCGC00015605-09, NCGC00015605-10, NCGC00015605-23, NCGC00015605-24, NCGC00022936-02, NCGC00022936-04, NCGC00022936-05, NCGC00261373-01, AC-10298, AC-32483, BL166799, Lamotrigine 100 microg/mL in Acetonitrile, SBI-0050666.P002, DB-014839, EU-0100688, L0241, NS00000354, SW197486-3, D00354, EN300-120680, W13018, AB00384359-16, AB00384359_17, AB00384359_18, F093440, Q410346, 3,5-diamino-(2,3-dichlorophenyl)-1,2,4-triazine, SR-01000000187-2, SR-01000000187-4, SR-01000000187-7, BRD-K93460210-001-22-9, BRD-K93460210-001-23-7, BRD-K93460210-071-01-6, SR-01000000187-10, 3,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazine, F2173-0540, Z1532338577, Lamotrigine Working Standard (Secondary Reference Standard), Lamotrigine, British Pharmacopoeia (BP) Reference Standard, Lamotrigine, European Pharmacopoeia (EP) Reference Standard, 1,2,4-TRIAZINE-3,5-DIAMINE, 6-(2,3-DICHLOROPHENYL), 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(lamotrigine), GI 267119X, 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamotrigine, United States Pharmacopeia (USP) Reference Standard, Lamotrigine, Pharmaceutical Secondary Standard, Certified Reference Material, Lamotrigine for peak identification, European Pharmacopoeia (EP) Reference Standard, Lamotrigine for system suitability, European Pharmacopoeia (EP) Reference Standard